Meridian Medica — Frankincense

01

Identity

Botanical Profile

Boswellia serrata Roxb. ex Colebr. — Oleo-gum-resin (exudate from bark incisions). Native to the dry hilly regions of India (Rajasthan, Madhya Pradesh, Gujarat); related species (B. sacra, B. carterii, B. papyrifera) from the Arabian Peninsula and East Africa

Resin: pale yellow to amber tears or irregular lumps. Aroma: warm, balsamic, slightly citrusy with pine and spice undertones. Taste: mildly bitter, slightly astringent with a warm resinous character. Burns with a sweet, rich, penetrating smoke.

Species Integrity

Boswellia serrata is the most clinically studied species, but the genus includes B. sacra, B. carterii, B. papyrifera, and B. frereana — each with different boswellic acid profiles. Only B. serrata has robust clinical trial data for joint inflammation.

02

Compounds

Active Compound Profile

Acetyl-11-keto-beta-boswellic acid (AKBA)

1–5% of crude resin; 20–30% in standardized extracts

Selective 5-lipoxygenase (5-LOX) inhibitor; NF-kB inhibition; topoisomerase I/II inhibitor; targets multiple inflammatory and proliferative pathways

11-keto-beta-boswellic acid (KBA)

3–8% of crude resin

5-LOX inhibition (less potent than AKBA); synergistic with other boswellic acids; anti-inflammatory via leukotriene synthesis inhibition

Beta-boswellic acid

15–25% of resin

Moderate 5-LOX inhibition; NF-kB modulation; contributes to overall anti-inflammatory activity of the resin complex

Incensole acetate

1–3% of resin

TRPV3 agonist; anxiolytic and antidepressant effects in animal models; neuroprotective

Absorption

Fat co-administration (critical): Boswellic acids are highly lipophilic pentacyclic triterpenes; fat vehicle increases absorption 5–10x by forming mixed micelles in the intestinal lumen

03

Pathways

Mechanism of Action

★★★☆☆ 5-Lipoxygenase (5-LOX) Inhibition AKBA directly binds to the 5-LOX enzyme active site, blocking conversion of arachidonic acid to pro-inflammatory leukotrienes (LTB4, LTC4, LTD4, LTE4)

★★★☆☆ NF-kB / Inflammatory Cytokine Axis Boswellic acids inhibit IKK-beta and prevent NF-kB nuclear translocation; reduces TNF-alpha, IL-1beta, IL-6 expression

★★★☆☆ Complement System Modulation Boswellic acids inhibit complement C3 convertase, reducing complement-mediated tissue destruction

★★★☆☆ Th1/Th2 Immune Rebalancing Boswellia shifts immune response from Th1-dominant (autoimmune) toward balanced Th1/Th2 profile; reduces IFN-gamma and IL-2 while modulating regulatory T cells

★★★☆☆ Gut Permeability / Mucosal Integrity Anti-inflammatory activity in the GI mucosa reduces intestinal inflammation; evidence in ulcerative colitis and Crohn's suggests mucosal healing properties

04

Biomarkers

What It Moves in Your Labs

Biomarker	Direction	Target	Mechanism
hs-CRP	Decrease	<1.0 mg/L	5-LOX inhibition and NF-kB suppression reduce systemic inflammatory marker production
ESR (Erythrocyte Sedimentation Rate)	Decrease	<20 mm/hr	Reduced leukotriene and prostaglandin synthesis decreases acute phase protein production
TPO Antibodies	Decrease	<35 IU/mL	Immune rebalancing (Th1/Th2 shift) and NF-kB suppression reduce autoantibody production over time
IL-6	Decrease	<3 pg/mL	Direct inhibition of IL-6 gene expression via NF-kB pathway suppression
blood pressure	mentioned	—	—
blood pressure	mentioned	—	—

05

Extraction

Extraction & Preparation

Standardized extract (30% AKBA): Concentrated boswellic acids; essential oils largely removed

Solubility · Lipophilic; practically insoluble in water; soluble in ethanol, oils, fats, DMSOMenstruum · 70% ethanolPlant material · Crushed resin tears (B. serrata)Maceration time · 4–6 weeks (agitate daily)Ratio · 1:5 (resin)

07

Dosing

Dosing Framework

Take boswellia with meals — fat co-administration is not optional, it is essential for absorption.

Dose 1

Standard: 300–400mg extract (30% AKBA), 2–3x daily

Most clinical trials use this range; always take with fat-containing meal

Dose 2

High: 400–500mg extract (30% AKBA), 3x daily

Higher dosing used in IBD trials; monitor for GI tolerance

Dose 3

Phytosome: 250mg Casperome, 2x daily

Lower dose with equivalent or superior blood levels due to phospholipid formulation

08

Synergies

Synergy Partners

★★★☆☆ Turmeric (Curcuma longa) Complementary anti-inflammatory pathways: boswellia inhibits 5-LOX while curcumin inhibits COX-2 and NF-kB; combined they block both major inflammatory cascades simultaneously

★★★☆☆ Black Pepper (Piper nigrum) Piperine inhibits CYP450 metabolism and P-glycoprotein efflux of boswellic acids, increasing systemic bioavailability

★★★☆☆ Ginger (Zingiber officinale) Complementary anti-inflammatory via COX/LOX dual inhibition; gingerols enhance GI absorption environment and reduce nausea

★★★☆☆ Ashwagandha (Withania somnifera) Ashwagandha provides adaptogenic and thyroid-supportive effects while boswellia addresses autoimmune inflammation; complementary HPA and immune axes

★★★☆☆ Omega-3 fatty acids (fish oil) Omega-3s resolve inflammation via specialized pro-resolving mediators (SPMs); boswellia blocks leukotriene synthesis — different but complementary anti-inflammatory endpoints

Signature Stack

THE DUAL BLOCK
Components: Frankincense (resin extract) + Turmeric (rhizome) + Black Pepper (fruit) + Ginger (rhizome) · Multi-pathway convergence: 5-LOX inhibition (AKBA) + COX-2 inhibition (curcumin) + NF-kB suppression (both) + bioavailability enhancement (piperine) + GI support (ginger) · The Dual Block simultaneously shuts down both the lipoxygenase and cyclooxygenase inflammatory cascades — a strategy that pharmaceutical NSAIDs cannot achieve without combining drugs. This is boswellia's unique contribution to the anti-inflammatory protocol. · Practical integration: Golden Ghee preparation daily; or standardized capsules of both taken together with a fat-containing meal and black pepper.

09

Safety

Contraindications & Interactions

Avoid Pregnancy / Lactation Boswellia has emmenagogue activity in traditional use and may stimulate uterine contractions at high doses. Limited modern safety data in pregnancy.

Minor Anticoagulant interaction Boswellic acids have mild antiplatelet activity and may enhance effects of warfarin and other anticoagulants.

Minor GI sensitivity at high doses Doses above 1200mg/day of crude extract may cause GI discomfort, acid reflux, or nausea in sensitive individuals. Paradoxically, moderate doses are GI-protective.

Minor Drug metabolism interactions Boswellic acids inhibit CYP1A2, CYP2C8, CYP2C9, CYP2D6, and CYP3A4 in vitro. Clinical significance at standard doses is unclear but theoretically relevant.

Minor Sustainability concerns Wild Boswellia populations are declining due to overtapping, fire, and habitat loss. Sustainable sourcing is an ethical imperative.

11

Evidence

Evidence Base

★★★★☆ Osteoarthritis / Joint Inflammation Strong — Multiple RCTs with consistent positive outcomes

★★★☆☆ Inflammatory Bowel Disease Moderate — Positive RCTs but limited in number

★★★☆☆ Asthma Moderate — Positive RCT with significant sample; needs replication

★★☆☆☆ Autoimmune Modulation Emerging — Strong mechanistic rationale; limited direct human evidence

★★☆☆☆ Neuroprotection / Cognitive Support Emerging — Animal data promising; human evidence preliminary

Evidence Gaps

The highest-value research gap for Meridian Medica: no published RCT has evaluated Boswellia serrata for Hashimoto's thyroiditis specifically. The mechanistic rationale is strong — 5-LOX inhibition, NF-kB suppression, Th1/Th2 rebalancing, and complement modulation all directly address autoimmune thyroid pathology. A controlled trial measuring TPO antibodies, thyroid function, and inflammatory markers in Hashimoto's patients receiving standardized boswellia extract would be highly informative.

Quality Alert

Boswellia adulteration is increasingly common as demand rises:

12

Protocol

Protocol Integration

Layer 1: Hypothalamic / Autonomic — HPA axis, circadian rhythm, stress response

Layer 2: Systemic Nutritional Repletion — Micronutrient optimization, antioxidant defense

Layer 3: Gut Permeability / Microbiome — Tight junction repair, motility, SIBO management

Recipe Integration

Golden Ghee (signature preparation)

1 tsp daily (~50–100mg boswellic acids)

Feed the Markers

Frankincense appears in the following Meridian Medica protocol contexts: